Skip to content
Scailyte
  • 5th-Year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • 5th-Year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch
Scailyte
  • 5th-year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • 5th-year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch
Scailyte
  • 5th-year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • 5th-year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
Scailyte
  • 5th-Year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
×
  • 5th-Year Anniversary Symposium
  • ScaiVision
  • Services
    • Cell & Gene Therapy
    • Immunology & Oncology
  • Discovery Pipeline
  • Publications
  • News
  • About us
Get in touch

Machine learning meets multi-omics for precision medicine

machine learning precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics powered by machine learning for precision medicine.

Continue reading

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte’s webinar on “Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies”.webinar single-cell endometriosis research

Continue reading

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

technical lead clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cell data analysis.

Continue reading

VACANCY: Data Scientist in Biomarker Discovery

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cell data analysis.

Continue reading

True precision medicine through single-cell science – Nature

True precision medicine single-cell science nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision medicine through single-cell science.

Continue reading

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single-cell analysis.

Continue reading

WEBINAR: Supervised learning of disease-associated cell states and dynamics

webinar supervised learning cell states

Watch Scailyte’s webinar on “Supervised learning of disease-associated cell states and dynamics” with Professor Dr Manfred Classen.

Continue reading

PODCAST: Discovering diseases with artificial intelligence

podcast discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams – Cat!apult with COO Dr. Corinne Solier.

Continue reading

Scailyte Closes Financing Round and Onboards Top Biotech Leaders

Scailyte closes Series A financing round and onboards top biotech leaders to fuel our growth in 2022​

Scailyte has successfully finished the first closing of their series A. Two new investors joined the round, and most of the existing shareholders engaged with follow-on investments. The second closing is planned for the first half of 2022 and Scailyte is currently in discussions with a number of additional investors.

Continue reading

Scailyte Quarterly Update December 2021

sScailyte quarterly update Q4 2021

December 2021 Quarterly update on Scailyte’s progress towards its mission to save millions of lives.

Continue reading
  • 1
  • 2
  • 3
  • 4
  • Next
Scailyte

Contact Information:

Scailyte AG
Lichtstrasse 35
4056 Basel
Switzerland

  • LinkedInCreated with Sketch.
  • D3255223-CCD2-41A0-AFD7-7F9CA3058D9C


USA Contact Information:
Scailyte AG
c/o swissnex Boston
420 Broadway,
Cambridge, MA 02138,
USA

  • Careers
  • Contact us
  • Home
  • Publications
  • News
  • About us
  • ScaiVision
  • Cell & Gene Therapy
  • Immunology & Oncology
  • Discovery Pipeline
Scailyte
Contact Information:

Scailyte AG
WSJ-500.1.101
Lichtstrasse 35
4056 Basel
Switzerland

  • LinkedInCreated with Sketch.
  • D3255223-CCD2-41A0-AFD7-7F9CA3058D9C
  • Clinical IVD Pipeline
  • ScaiVision
  • Partnering
  • Home
  • About
  • News
  • Careers
  • Contact us

Scailyte 2021 © All rights reserved. Scailyte, ScaiVision and the Scailyte logo are registered trademarks.

Terms & Conditions